The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-PD-1 Antibody Market Research Report 2025

Global Anti-PD-1 Antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1601061

No of Pages : 104

Ask Your Query

Synopsis

Anti-PD-1 Antibody is used to inhibit PD-1 and its downstream signaling pathways.

The global Anti-PD-1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Anti-PD-1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Anti-PD-1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Anti-PD-1 Antibody include Bio X Cell, Thermo Fisher, InvivoGen, BioVision Inc, Abcam, Bristol-Myers Squibb (BMS), Merck, Ono Pharmaceutical Co., Ltd and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Anti-PD-1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-PD-1 Antibody.

Report Scope

The Anti-PD-1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-PD-1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-PD-1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Bio X Cell
  • Thermo Fisher
  • InvivoGen
  • BioVision Inc
  • Abcam
  • Bristol-Myers Squibb (BMS)
  • Merck
  • Ono Pharmaceutical Co., Ltd
  • Lilly
  • Chugai Pharmaceutical Co., Ltd
  • BeiGene
  • Abbvie
  • TG Therapeutics, Inc
  • Novartis
  • Arcus Biosciences
  • Sino Biological Inc
  • 3SBio Inc

Segment by Type

  • Monoclonal
  • Polyclonal

Segment by Application

  • IHC-P
  • ICC/IF
  • WB
  • Flow Cytometry
  • ELISA

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-PD-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-PD-1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Anti-PD-1 Antibody Market Overview
1.1 Product Overview and Scope of Anti-PD-1 Antibody
1.2 Anti-PD-1 Antibody Segment by Type
1.2.1 Global Anti-PD-1 Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-PD-1 Antibody Segment by Application
1.3.1 Global Anti-PD-1 Antibody Market Value by Application: (2024-2030)
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-PD-1 Antibody Revenue 2019-2030
1.4.2 Global Anti-PD-1 Antibody Sales 2019-2030
1.4.3 Global Anti-PD-1 Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-PD-1 Antibody Market Competition by Manufacturers
2.1 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-PD-1 Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Anti-PD-1 Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-PD-1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-PD-1 Antibody, Product Type & Application
2.7 Anti-PD-1 Antibody Market Competitive Situation and Trends
2.7.1 Anti-PD-1 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-PD-1 Antibody Players Market Share by Revenue
2.7.3 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-PD-1 Antibody Retrospective Market Scenario by Region
3.1 Global Anti-PD-1 Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-PD-1 Antibody Global Anti-PD-1 Antibody Sales by Region: 2019-2030
3.2.1 Global Anti-PD-1 Antibody Sales by Region: 2019-2024
3.2.2 Global Anti-PD-1 Antibody Sales by Region: 2025-2030
3.3 Global Anti-PD-1 Antibody Global Anti-PD-1 Antibody Revenue by Region: 2019-2030
3.3.1 Global Anti-PD-1 Antibody Revenue by Region: 2019-2024
3.3.2 Global Anti-PD-1 Antibody Revenue by Region: 2025-2030
3.4 North America Anti-PD-1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-PD-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-PD-1 Antibody Sales by Country (2019-2030)
3.4.3 North America Anti-PD-1 Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-PD-1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-PD-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-PD-1 Antibody Sales by Country (2019-2030)
3.5.3 Europe Anti-PD-1 Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-PD-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-PD-1 Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-PD-1 Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-PD-1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-PD-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-PD-1 Antibody Sales by Country (2019-2030)
3.7.3 Latin America Anti-PD-1 Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-PD-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-PD-1 Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-PD-1 Antibody Sales by Type (2019-2030)
4.1.1 Global Anti-PD-1 Antibody Sales by Type (2019-2024)
4.1.2 Global Anti-PD-1 Antibody Sales by Type (2025-2030)
4.1.3 Global Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
4.2 Global Anti-PD-1 Antibody Revenue by Type (2019-2030)
4.2.1 Global Anti-PD-1 Antibody Revenue by Type (2019-2024)
4.2.2 Global Anti-PD-1 Antibody Revenue by Type (2025-2030)
4.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Anti-PD-1 Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-PD-1 Antibody Sales by Application (2019-2030)
5.1.1 Global Anti-PD-1 Antibody Sales by Application (2019-2024)
5.1.2 Global Anti-PD-1 Antibody Sales by Application (2025-2030)
5.1.3 Global Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
5.2 Global Anti-PD-1 Antibody Revenue by Application (2019-2030)
5.2.1 Global Anti-PD-1 Antibody Revenue by Application (2019-2024)
5.2.2 Global Anti-PD-1 Antibody Revenue by Application (2025-2030)
5.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Anti-PD-1 Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bio X Cell
6.1.1 Bio X Cell Corporation Information
6.1.2 Bio X Cell Description and Business Overview
6.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bio X Cell Anti-PD-1 Antibody Product Portfolio
6.1.5 Bio X Cell Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Anti-PD-1 Antibody Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 InvivoGen
6.3.1 InvivoGen Corporation Information
6.3.2 InvivoGen Description and Business Overview
6.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 InvivoGen Anti-PD-1 Antibody Product Portfolio
6.3.5 InvivoGen Recent Developments/Updates
6.4 BioVision Inc
6.4.1 BioVision Inc Corporation Information
6.4.2 BioVision Inc Description and Business Overview
6.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioVision Inc Anti-PD-1 Antibody Product Portfolio
6.4.5 BioVision Inc Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abcam Anti-PD-1 Antibody Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 Bristol-Myers Squibb (BMS)
6.6.1 Bristol-Myers Squibb (BMS) Corporation Information
6.6.2 Bristol-Myers Squibb (BMS) Description and Business Overview
6.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
6.6.5 Bristol-Myers Squibb (BMS) Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Anti-PD-1 Antibody Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Ono Pharmaceutical Co., Ltd
6.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.8.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lilly Anti-PD-1 Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Chugai Pharmaceutical Co., Ltd
6.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
6.10.2 Chugai Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 BeiGene
6.11.1 BeiGene Corporation Information
6.11.2 BeiGene Anti-PD-1 Antibody Description and Business Overview
6.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BeiGene Anti-PD-1 Antibody Product Portfolio
6.11.5 BeiGene Recent Developments/Updates
6.12 Abbvie
6.12.1 Abbvie Corporation Information
6.12.2 Abbvie Anti-PD-1 Antibody Description and Business Overview
6.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbvie Anti-PD-1 Antibody Product Portfolio
6.12.5 Abbvie Recent Developments/Updates
6.13 TG Therapeutics, Inc
6.13.1 TG Therapeutics, Inc Corporation Information
6.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Description and Business Overview
6.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
6.13.5 TG Therapeutics, Inc Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Anti-PD-1 Antibody Description and Business Overview
6.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novartis Anti-PD-1 Antibody Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Arcus Biosciences
6.15.1 Arcus Biosciences Corporation Information
6.15.2 Arcus Biosciences Anti-PD-1 Antibody Description and Business Overview
6.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
6.15.5 Arcus Biosciences Recent Developments/Updates
6.16 Sino Biological Inc
6.16.1 Sino Biological Inc Corporation Information
6.16.2 Sino Biological Inc Anti-PD-1 Antibody Description and Business Overview
6.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
6.16.5 Sino Biological Inc Recent Developments/Updates
6.17 3SBio Inc
6.17.1 3SBio Inc Corporation Information
6.17.2 3SBio Inc Anti-PD-1 Antibody Description and Business Overview
6.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.17.4 3SBio Inc Anti-PD-1 Antibody Product Portfolio
6.17.5 3SBio Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-PD-1 Antibody Industry Chain Analysis
7.2 Anti-PD-1 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-PD-1 Antibody Production Mode & Process
7.4 Anti-PD-1 Antibody Sales and Marketing
7.4.1 Anti-PD-1 Antibody Sales Channels
7.4.2 Anti-PD-1 Antibody Distributors
7.5 Anti-PD-1 Antibody Customers
8 Anti-PD-1 Antibody Market Dynamics
8.1 Anti-PD-1 Antibody Industry Trends
8.2 Anti-PD-1 Antibody Market Drivers
8.3 Anti-PD-1 Antibody Market Challenges
8.4 Anti-PD-1 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock